|
A member of many scientific societies, Bill E. Cham, Ph.D., is
frequently invited to speak at conferences on his research topics.
His research interests cover a wide range of disciplines resulting
in publication of over a hundred articles on topics ranging from
pharmacology, iron metabolism, mineral research, lipidology and
oncology. His research in lipidology starting from test tube observations,
have led to clinical trials in the USA for the treatment of atherosclerosis,
HIV, and AIDS.
His work in oncology has produced Curaderm BEC5 for the treatment
of skin cancers. Human clinical trials in Australia are currently
underway to establish whether BEC can also treat terminal internal
cancers effectively.
Dr. Cham’s research is acknowledged worldwide and many scientists
are focused on extending his original discovery and research observations.
See also: Bill Cham Interview
|
